EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review

Kevin J J Kwinten iD, Victor A Lemain, Joanne A de Hullu, William P J Leenders, Miranda P Steenbeek, Anne M van Altena, Johanna M A Pijnenborg

Cancer Medicine · 2024-07 · 13 (14)

DOI: 10.1002/cam4.70000 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cancer Medicine, online erschienen am 19.07.2024. Verfasst von Kevin J J Kwinten und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Endometrial Neoplasms, DNA Methylation, Early Detection of Cancer, Ovarian Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In the last decade, technical innovations have resulted in the development of several minimally invasive diagnostic cancer tools. Within women at high risk of developing ovarian cancer (OC) or endometrial cancer (EC) due to a hereditary cancer syndrome, there is an urgent need for minimally invasive and patient‐friendly methods to detect OC and EC at an early stage. Materials and Methods We performed a systematic search of studies using DNA methylation or mutation analysis, microbiome, or proteomics performed on cervicovaginal specimens (smear, swab, or tampon) intended to detect OC and EC published until January 2024.

Results

Included studies ( n = 36) showed high heterogeneity in terms of biomarkers used and outcomes, and only a few studies reported on the detection of biomarkers in high‐risk subgroups.

Conclusion

Based on the findings in this review, DNA methylation techniques seem to be the most promising for detecting OC and EC at early stages in the general population. Future validation of cervicovaginal DNA methylation techniques is needed to determine whether this technique might be beneficial in hereditary high‐risk subgroups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsDNA MethylationEarly Detection of CancerOvarian NeoplasmsBiomarkers, TumorHumansFemaleVaginaCervix UteriProteomics

Stichwörter der Autor:innen

biomarkersearly detectionendometrial cancerovarian cancer

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Obstetrics and Gynecology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
  • Predica Diagnostics, Nijmegen, The Netherlands.
  • Department of Obstetrics and Gynecology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.

ORCID-Profile: Kevin J J Kwinten

Zitieren

APA

Kwinten, K. J. J., Lemain, V. A., de Hullu, J. A., Leenders, W. P. J., Steenbeek, M. P., van Altena, A. M., & Pijnenborg, J. M. A. (2024). Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review. Cancer Medicine, 13(14). https://doi.org/10.1002/cam4.70000

Vancouver

Kwinten KJJ, Lemain VA, de Hullu JA, Leenders WPJ, Steenbeek MP, van Altena AM, et al. Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review. Cancer Medicine. 2024;13(14). doi:10.1002/cam4.70000

BibTeX
@article{Kwinten2024,
  author = {Kwinten, Kevin J J and Lemain, Victor A and de Hullu, Joanne A and Leenders, William P J and Steenbeek, Miranda P and van Altena, Anne M and Pijnenborg, Johanna M A},
  title = {Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review},
  journal = {Cancer Medicine},
  year = {2024},
  volume = {13},
  number = {14},
  doi = {10.1002/cam4.70000}
}
Kostenlos starten →